NL-OMON52793已完成不适用
Validation of mutation analysis in circulating tumor DNA with a ddPCR assay as diagnostic and follow-up tool for patients with a KIT exon 11 mutated GIST: GALLOP-11 - GALLOP-11
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Patients with GIST with a by biopsy confirmed primary KIT exon 11 mutation
- •covered by our KIT exon 11 ddPCR assay (mutation/deletion within target
- •sequence of c.1665 to c.1736);
- •2. Patients with an indication for at least 4 CT-scans (and/or MRI scans)
- •concomitant with regular laboratory examination in a neoadjuvant, adjuvant
- •and/or palliative care trajectory within the time frame of the study;
- •3. Age >=18 years;
- •4. Written informed consent provided.
排除标准
- •1. Patients who are unable to comply with study procedures and follow up.
研究者
相似试验
已完成
不适用
The GALLOP-11 StudyGastro-intestinal Stromal TumorsNCT05178030University Medical Center Groningen243
进行中（未招募）
不适用
A study to assess the incidence in the UK of a change in a protein found in patients with newly diagnosed non-small cell lung cancer which has advanced or spread, and to investigate the quality of life of these patients when they receive treatment with erlotinib (Tarceva®) alone as a first treatment for this stage of their disease.EUCTR2010-021120-96-GBRoche Products Limited1,200
已完成
不适用
A feasibility study of performance of a novel method for gene mutations in circulating tumor DNAnon-small cell lung cancerJPRN-UMIN000038679West Japan Oncology Group10
已完成
不适用
Exploratory study on somatic mutation detection using plasma DNA from patients with lung cancerlung cancerJPRN-UMIN000021711Third Department of Internal Medicine, Wakayama Medical University80
已完成
不适用
ARTEMIS DIANE T790M (An Amino Acid Substitution at Position 790 in EGFR, From a Threonine (T) to a Methionine (M)) Mutation at Hospital Laboratories in Comparison With Central LaboratoryLocally Advanced or Metastatic EGFR(+) NSCLC PatientsNCT02991274AstraZeneca897